Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
CGIX Cancer Genetics, Inc. daily Stock Chart
CGIX [NASD]
Cancer Genetics, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-7.67 Insider Own24.60% Shs Outstand2.31M Perf Week-13.30%
Market Cap14.00M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.76M Perf Month107.53%
Income-10.90M PEG- EPS next Q- Inst Own12.30% Short Float15.61% Perf Quarter116.04%
Sales12.20M P/S1.15 EPS this Y-171.80% Inst Trans-19.54% Short Ratio0.38 Perf Half Y21.83%
Book/sh3.71 P/B1.63 EPS next Y- ROA-43.30% Target Price3.00 Perf Year-44.66%
Cash/sh0.91 P/C6.67 EPS next 5Y40.00% ROE-212.20% 52W Range2.00 - 20.70 Perf YTD-16.53%
Dividend- P/FCF- EPS past 5Y22.40% ROI-122.80% 52W High-70.72% Beta2.45
Dividend %- Quick Ratio1.00 Sales past 5Y33.00% Gross Margin44.70% 52W Low202.52% ATR1.01
Employees218 Current Ratio1.00 Sales Q/Q320.00% Oper. Margin-57.00% RSI (14)52.54 Volatility9.73% 23.25%
OptionableYes Debt/Eq0.32 EPS Q/Q36.70% Profit Margin- Rel Volume0.34 Prev Close6.68
ShortableYes LT Debt/Eq0.01 EarningsNov 25 BMO Payout- Avg Volume730.70K Price6.06
Recom3.00 SMA209.20% SMA5035.12% SMA20017.00% Volume247,414 Change-9.28%
Dec-07-17Initiated Maxim Group Buy $6
Jun-27-17Initiated Dawson James Buy
Jun-26-17Initiated The Benchmark Company Speculative Buy $6
Sep-26-16Initiated Rodman & Renshaw Buy $6
Nov-20-19 08:00AM  Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update GlobeNewswire +131.25%
Nov-14-19 05:29AM  Introducing Cancer Genetics (NASDAQ:CGIX), The Stock That Collapsed 98% Simply Wall St. -5.82%
Oct-24-19 04:15PM  Cancer Genetics, Inc. Announces Strategic Transactions GlobeNewswire -19.06%
08:30AM  Cancer Genetics Announces 1-for-30 Reverse Stock Split GlobeNewswire
Oct-17-19 06:55AM  Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners GlobeNewswire
Aug-20-19 08:00AM  Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update GlobeNewswire
Jul-16-19 12:44PM  A Look At Benzinga Pro's Most-Searched Tickers For July 16, 2019 Benzinga +18.52%
08:44AM  Cancer Genetics Sharply Higher After Interpace Buys Biopharma Unit Benzinga
Jul-15-19 04:22PM  Cancer Genetics, Inc. Announces Strategic Transactions GlobeNewswire
04:10PM  Interpace Diagnostics Acquires Cancer Genetics Biopharma Services Business Supported by Investment from Ampersand Capital Partners GlobeNewswire
Jun-25-19 07:24AM  Triangle pharma brings in new CFO looking for capital American City Business Journals
Jun-24-19 07:00AM  Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer GlobeNewswire
Jun-05-19 02:00AM  LabCorp (LH) Closes Envigo Swap Deal, Expands in CRO Space Zacks
May-20-19 05:06PM  Cancer Genetics: 1Q Earnings Snapshot Associated Press
05:00PM  Cancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business Update GlobeNewswire
Apr-16-19 07:22AM  Cancer Genetics: 4Q Earnings Snapshot Associated Press
07:00AM  Cancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Strategic Business Updates GlobeNewswire
Mar-26-19 08:06AM  Investors Who Bought Cancer Genetics (NASDAQ:CGIX) Shares Five Years Ago Are Now Down 98% Simply Wall St.
Feb-14-19 07:04AM  Could The Cancer Genetics, Inc. (NASDAQ:CGIX) Ownership Structure Tell Us Something Useful? Simply Wall St.
Jan-31-19 04:01PM  Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock GlobeNewswire
Jan-29-19 07:25AM  The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive Benzinga -15.75%
Jan-28-19 10:33PM  Cancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common Stock GlobeNewswire
04:00PM  Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-21-19 09:21AM  Insider Buys Of The Week: Cancer Genetics, Dish Network, Valvoline Benzinga
Jan-16-19 08:45AM  Cancer Genetics Issues Letter to Shareholders GlobeNewswire +6.56%
Jan-14-19 05:29PM  Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock GlobeNewswire -6.58%
Jan-10-19 08:27AM  The Daily Biotech Pulse: Cancer Genetics Prices Offering, DiaMedica Delists From Canadian Exchange, Medigus CEO Quits Benzinga -14.88%
Jan-09-19 11:20PM  Cancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock GlobeNewswire -10.23%
04:00PM  Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
08:00AM  Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services GlobeNewswire
Dec-17-18 08:00AM  Cancer Genetics Terminates Proposed Merger with NovellusDx GlobeNewswire -40.04%
Dec-14-18 06:55AM  Today's Research Reports on Trending Tickers: Adial Pharmaceuticals and Cancer Genetics ACCESSWIRE +52.05%
Nov-21-18 08:04AM  The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO Benzinga +11.97%
Nov-19-18 05:40PM  Cancer Genetics (CGIX) Reports Q3 Loss, Lags Revenue Estimates Zacks -8.42%
04:33PM  Cancer Genetics: 3Q Earnings Snapshot Associated Press
04:16PM  Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates GlobeNewswire
Nov-14-18 04:01PM  Cancer Genetics Appoints Glenn Miles as Chief Financial Officer GlobeNewswire -10.65%
Nov-01-18 11:28AM  Will Cancer Genetics (CGIX) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-18-18 09:05AM  Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China GlobeNewswire +6.15%
Oct-16-18 08:00AM  Cancer Genetics Issues Letter to Shareholders GlobeNewswire
Oct-08-18 07:00AM  Cancer Genetics and Cellaria Partner on Precision Medicine Tools GlobeNewswire
Sep-28-18 06:31PM  Robbins Arroyo LLP: Cancer Genetics, Inc. (CGIX) Sued by Shareholders in Recently Filed Class Action Business Wire
Sep-25-18 04:01PM  Cancer Genetics Enters Supply Agreement with Agilent Technologies GlobeNewswire
Sep-20-18 08:30AM  Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials GlobeNewswire +5.09%
Sep-18-18 12:14PM  Chardan Advises NovellusDX in Cross-Border Biotech Merger PR Newswire
08:30AM  Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge GlobeNewswire
Aug-29-18 11:54PM  Edited Transcript of CGIX earnings conference call or presentation 14-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-17-18 11:51AM  Four years after buying Morrisville firm, this out-of-town CEO wants to bolster NC ops American City Business Journals
Aug-14-18 07:49AM  Cancer Genetics: 2Q Earnings Snapshot Associated Press
07:30AM  Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates GlobeNewswire
06:30AM  Cancer Genetics, Inc. to Host Earnings Call ACCESSWIRE
Aug-13-18 02:33PM  Cancer Genetics Q2 Earnings Preview Benzinga
Aug-07-18 04:05PM  Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018 GlobeNewswire
Jul-18-18 04:05PM  Cancer Genetics Closes $2.625 million Convertible Note Financing GlobeNewswire
Jul-12-18 07:25AM  Free Research Reports on DexCom and Three More Medical Research Stocks ACCESSWIRE
Jun-19-18 04:18PM  Edited Transcript of CGIX earnings conference call or presentation 15-May-18 12:30pm GMT Thomson Reuters StreetEvents
Jun-12-18 08:00AM  Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer GlobeNewswire
Jun-04-18 04:00PM  Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Cancer Genetics, Inc. (CGIX) Business Wire
01:30PM  DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:27AM  FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018 ACCESSWIRE
Jun-01-18 08:00PM  3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
07:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline CGIX ACCESSWIRE
04:06PM  CANCER GENETICS LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in Cancer Genetics, Inc. to Contact the Firm Business Wire
03:48PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Cancer Genetics, Inc. (CGIX) and Encourages Investors to Contact the Firm Before June 4th GlobeNewswire
May-31-18 04:30PM  MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
May-30-18 08:00PM  Safirstein Metcalf LLP Reminds Investors That A Class Action Has Been Filed Against Cancer Genetics, Inc. CGIX GlobeNewswire
06:21PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline CGIX Business Wire
10:01AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018 ACCESSWIRE
May-29-18 01:23PM  Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Cancer Genetics, Inc. (CGIX) GlobeNewswire
May-28-18 09:30AM  CGIX JUNE 4 DEADLINE: Rosen Law Firm Reminds Cancer Genetics, Inc. Investors of Important Deadline in First Filed Case CGIX Business Wire
May-26-18 07:51AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX ACCESSWIRE
May-25-18 07:30AM  Complimentary Technical Snapshots on Bruker and Three More Medical Research Stocks ACCESSWIRE +5.09%
May-24-18 07:33PM  CGIX $100,000 Threshold: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Cancer Genetics, Inc. Investors GlobeNewswire -6.26%
May-23-18 05:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline CGIX ACCESSWIRE +8.92%
10:08AM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018 ACCESSWIRE
May-19-18 08:13AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX ACCESSWIRE
May-17-18 01:40PM  CGIX DEADLINE: Pawar Law Reminds Investors of Important June 4, 2018 Lead Plaintiff Deadline in Class Action ACCESSWIRE
May-16-18 01:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline CGIX Business Wire
10:06AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018 ACCESSWIRE
May-15-18 10:14AM  CGIX DEADLINE: Rosen Law Firm Reminds Cancer Genetics, Inc. Investors of Important Deadline in First Filed Case CGIX GlobeNewswire
09:37AM  DEADLINE ALERT: Shareholder Class Action Filed Against Cancer Genetics, Inc. - CGIX ACCESSWIRE
07:24AM  Cancer Genetics: 1Q Earnings Snapshot Associated Press
07:00AM  Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates GlobeNewswire
06:45AM  Cancer Genetics, Inc. to Host Earnings Call ACCESSWIRE
May-12-18 07:46AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX ACCESSWIRE
May-10-18 08:31PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Cancer Genetics, Inc. Investors (CGIX) Business Wire
04:05PM  Cancer Genetics to Report First Quarter 2018 Financial Results on May 15, 2018 GlobeNewswire
11:45AM  INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) & Lead Plaintiff Deadline - June 4, 2018 GlobeNewswire
09:15AM  Important Deadline Notice for Cancer Genetics, Inc. Shareholders - CGIX ACCESSWIRE
May-09-18 05:15PM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cancer Genetics, Inc. and Encourages Investors with Losses to Contact The Firm ACCESSWIRE
03:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX ACCESSWIRE
May-08-18 06:40PM  Deadline Alert for Cancer Genetics, Inc. Shareholders in Class Action Lawsuit - CGIX ACCESSWIRE
04:20PM  PAWAR LAW: Important June 4, 2018 Lead Plaintiff Deadline in Cancer Genetics, Inc. Class Action- CGIX ACCESSWIRE
12:19PM  CANCER GENETICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action has been filed against Cancer Genetics, Inc. in the United States District Court for the District of New Jersey GlobeNewswire
07:30AM  Lawsuit for Investors in Cancer Genetics, Inc. (NASDAQ: CGIX) with Substantial Financial Losses Announced by Shareholders Foundation ACCESSWIRE
May-06-18 02:40PM  Kaskela Law LLC: Shareholder Class Action Filed Against Cancer Genetics, Inc. - CGIX GlobeNewswire
May-05-18 08:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX PR Newswire
May-03-18 10:28AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) & Lead Plaintiff Deadline - June 4, 2018 ACCESSWIRE
May-02-18 09:50PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX ACCESSWIRE
Cancer Genetics, Inc., through its subsidiary, vivoPharm, Pty Ltd., provides contract research services primarily focusing on studies to guide drug discovery and development programs in the oncology and immuno-oncology fields in the United States, Europe, and the Asia Pacific. Its clinical offerings include a portfolio of proprietary tests, such as comparative genomic hybridization microarrays and next generation sequencing panels, gene expression tests, and DNA fluorescent in situ hybridization probes targeting hematological, urogenital, and HPV-associated cancers, in conjunction with ancillary non-proprietary tests. The company also offers a range of non-proprietary oncology-focused tests and laboratory services to oncologists and pathologists at hospitals, cancer centers, and physician offices, as well as biotech and pharmaceutical companies to support their clinical trials. Cancer Genetics, Inc. was founded in 1999 and is based in Rutherford, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Miles Michael GlennChief Financial OfficerJan 31Buy0.23150,00034,500150,000Feb 01 04:01 PM
ROBERTS JOHN AChief Executive OfficerJan 31Buy0.23185,43642,650297,636Feb 01 04:02 PM
PAPPAJOHN JOHNDirectorJan 31Buy0.231,000,000230,0004,781,204Feb 01 04:00 PM
Cannon EdmundDirectorJan 31Buy0.2343,47910,00061,873Feb 01 04:01 PM
Harris Geoffrey E.DirectorJan 14Buy0.23100,00022,500127,500Jan 16 04:47 PM
PAPPAJOHN JOHNDirectorJan 14Buy0.231,000,000225,0003,781,204Jan 16 04:45 PM
ROBERTS JOHN AChief Executive OfficerJan 14Buy0.23100,00022,500112,200Jan 16 04:42 PM
open in yahoo | open in reuters | open in google